Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 184 | 190 | 482 | 660 | 748 |
| Cost of Goods | 91 | 206 | 219 | 319 | 409 |
| Gross Profit | 93 | -17 | 263 | 341 | 339 |
| Operating Expenses | 13,109 | 11,305 | 9,026 | 8,651 | 6,984 |
| Operating Income | -12,926 | -11,116 | -8,543 | -7,991 | -6,236 |
| Other Income | 29 | 24 | 9 | 3 | 6 |
| Pre-tax Income | -12,896 | -11,092 | -8,534 | -7,988 | -6,230 |
| Net Income Continuous | -12,896 | -10,784 | -8,534 | -7,988 | -6,230 |
| Net Income | $-12,896 | $-10,784 | $-8,534 | $-7,988 | $-6,230 |
| EPS Basic Total Ops | -0.49 | 0.88 | -0.47 | -1.61 | -1.26 |
| EPS Basic Continuous Ops | -0.49 | 0.87 | -0.47 | -1.61 | -1.26 |
| EPS Diluted Total Ops | -0.49 | 0.88 | -0.47 | -1.61 | -1.26 |
| EPS Diluted Continuous Ops | -0.49 | 0.87 | -0.47 | -1.61 | -1.26 |
| EBITDA(a) | $-12,622 | $-10,942 | $-8,497 | $-7,956 | $-6,202 |